Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colonic Neoplasms 50Rectal Neoplasms 49Colorectal Neoplasms 36Pancreatic Neoplasms 10Unspecified Adult Solid Tumor, Protocol Specific 9Neoplasm Metastasis 8Stomach Neoplasms 7Ovarian Neoplasms 6Carcinoma, Hepatocellular 6Lymphoma, Large B-Cell, Diffuse 5Gallbladder Neoplasms 5Carcinoma, Ovarian Epithelial 5Bile Duct Neoplasms 5Burkitt Lymphoma 4Appendiceal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Neoplasms 3Fallopian Tube Neoplasms 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Osteosarcoma 2Optic Nerve Glioma 2Neurotoxicity Syndromes 2Neuroectodermal Tumors, Primitive, Peripheral 2Nasopharyngeal Neoplasms 2Melanoma 2Lymphoma, T-Cell, Peripheral 2

Interventions

veliparib 1dabrafenib 1Taxes 1Plasmapheresis 1Pharmacogenomic Testing 1Paclitaxel 1Oxaliplatin 1Kidney Transplantation 1Drug Therapy 1Dexamethasone 1Carboplatin 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Renal Insufficiency × Oxaliplatin × Clear all
NCT00001835 2008-03-04

Oxaliplatin in Cancer Patients With Impaired Kidney Function

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
60 enrolled
Genitourinary

Kidney Diseases, Kidney Neoplasms, Neoplasm Metastasis, Neoplasms, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡